Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, Myanmar

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Kim, Tong Soo ^a,b   Kim, Hyung Hwan ^c,h   Kim, Jung Yeon ^b   Kong, Yoon ^d   Na, Byoung Kuk ^e   Lin, Khin ^f   Moon, Sung Ung ^b   Kim, Yeon Joo ^b   Kwon, Myoung Hee ^b   Sohn, Youngjoo ^g   Kim, Hyuck ^h   Lee, Hyeong Woo ^b,i  

^a Inha University School of Medicine   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Sungkyunkwan University   (South Korea)

^e Gyeongsang National University School of Medicine   (South Korea)

^f Pying Oo Lwin Township ^*  (Myanmar)

^g Department of Computer and Electronic Physics   (South Korea)

^h Jungwon University   (South Korea)

ⁱ UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CIRCUMSPOROZOITE PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PFLSA 1 ANTIGEN; PFLSA 3 ANTIGEN; PROTOZOON ANTIBODY; PVS25 ANTIGEN; PVS28 ANTIGEN; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; PARASITE ANTIGEN;

ADULT; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; BLOOD SMEAR; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; MALARIA FALCIPARUM; MALE; MICROSCOPY; MYANMAR; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; BLOOD; EVALUATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; MALARIA, FALCIPARUM; MALARIA, VIVAX; MICROSCOPY; MYANMAR; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SENSITIVITY AND SPECIFICITY;

EID: 79961101430     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-228     Document Type: Article

References (29)

1. Vector Borne Diseases Control Project-Department of Health, Annual Report Myanmar 1997
2. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Guerin-Marchand C, Druilhe P, Galey B, Londono A, Patarapotikul J, Beaudoin RL, Dubeaux C, Tartar A, Mercereau-Puijalon O, Langsley G, Nature 1987 329 164 167 10.1038/329164a0 3306406 (Pubitemid 17125254)
3. Cytotoxic T-lymphocyte epitopes for HLA-B-53 and other HLA types in the malaria vaccine candidate liver stage antigen 3. Aidoo M, Lalvani A, Gilbert S, Hu JT, Daubersies P, Hurt N, Whittle HC, Druilhe P, Hill AVS, Infect Immun 2000 68 227 232 10.1128/IAI.68.1.227-232.2000 10603392 (Pubitemid 30016701)
4. Analysis of immune response against T-and B-cell epitopes from Plasmodium falciparum liver stage antigen 1 in rodent malaria models and malaria exposed human subject in India. Joshi SK, Bharadwaj A, Chatterjee S, Chauhan VS, Infect Immun 2000 68 141 150 10.1128/IAI.68.1.141-150.2000 10603380 (Pubitemid 30016689)
5. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent induces of B helper, T helper and cytolytic T cell responses in mice. Perlaza BL, Sauzet JP, Balde AT, Brahimi K, Tall A, Corradin G, Druilhe P, Eur J Immunol 2001 31 2200 2209 10.1002/1521-4141(200107)31:7<2200::AID-IMMU2200>3.0.CO;2-L 11449374 (Pubitemid 32640737)
6. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Daubersies P, Thomas AW, Millet P, Brahimi K, Langermans JA, Ollomo B, BenMohamed L, Slierendregt B, Eling W, Van Belkum, Dubreuil G, Meis JF, Guérin-Marchand C, Cayphas S, Cohen J, Gras-Masse H, Druilhe P, Nat Med 2000 6 1412 11100131 (Pubitemid 32001031)
7. Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine. Kutis JD, Hollingdale MR, Luty AJ, Lanar DE, Krzych U, Duffy PE, Trends Parasitol 2001 17 219 223 10.1016/S0169-4758(00)01862-7 11323304 (Pubitemid 32422165)
8. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge. Sauzet JP, Perlaza BL, Brahimi K, Daubersies P, Druilhe P, Infect Immun 2001 69 1202 1206 10.1128/IAI.69.2.1202-1206.2001 11160023 (Pubitemid 32109594)
9. Immunity to liver stage malaria: considerations for vaccine design. Taylor-Robinson AW, Immun Research 2003 27 53 70 10.1385/IR:27:1:53 (Pubitemid 36349766)
10. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. Arnot DE, Barnwell JW, Tam JP, Nussenzweig V, Nussenzweig RS, Enea V, Science 1985 230 815 818 10.1126/science.2414847 2414847 (Pubitemid 16193972)
11. Diversity in the immunodominant determinants of the circumsporozoite protein of Plasmodium falciparum parasites from malaria endemic regions of Papua New Guinea and Brazil. Shi YP, Alpers MP, Povoa MM, Lal AA, Am J Trop Med Hyg 1992 47 844 851 1281968 (Pubitemid 23019157)
12. Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Rosenberg R, Wirtz RA, Lanar DE, Sattabongkot J, Hall T, Waters AP, Prasittisuk C, Science 1989 245 973 976 10.1126/science.2672336 2672336 (Pubitemid 19224827)
13. Use of PCR/DNA probes to identify circumsporozoite genotype of Plasmodium vivax in China. Han GD, Zhang XJ, Zhang HH, Chen XX, Huang BC, Southeast Asian J Trop Med Pub Hlth 1999 30 20 23
14. Anophelines in the state of Acre, Brazil, infected with Plasmodium falciparum, P. vivax, the variant P. vivax VK247 and P. malariae. Branquinho MS, Lagos CB, Rocha RM, Natal D, Barata JM, Cochrane AH, Nardin E, Nussenzweig RS, Kloetzel JK, Trans R Soc Trop Med Hyg 1993 87 391 394 10.1016/0035-9203(93) 90008-E 8249059
15. Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens. Kain KC, Brown AE, Webster HK, Wirtz RA, Keystone JS, Rodriguez MH, Kinahan J, Rowland M, Lanar DE, J Clin Microbiol 1992 30 1863 1866 1629344
16. Serologic and genetic characterization of Plasmodium vivax from whole blood-impregnated filter paper discs. Kain KC, Wirtz RA, Fernandez I, Franke ED, Rodriguez MH, Lanar DE, Am J Trop Med Hyg 1992 46 473 479 1575295
17. Plasmodium vivax VK247 and VK210 circumsporozoite proteins in Anopheles mosquitoes from Andoas. Peru. Need JT, Wirtz RA, Franke ED, Fernandez R, Carbajal F, Falcon R, San Roman E, J Med Entomol 1993 30 597 600 8510119
18. Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. Stowers AW, Tsuboi T, Collins WE, Sattabongkot JS, Suwanabun N, Infect Immun 2000 68 6618 6623 10.1128/IAI.68.12.6618-6623.2000 11083773 (Pubitemid 32463362)
19. Application of the indirect fluorescent antibody method in a study of malaria endemicity in Mato Grosso, Brazil. Jeffery GM, McWilson W, Collins WE, Lobel H, Am Trop Med Hyg 1975 24 402 411
20. Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil. Cerutti C Jr, Boulos M, Coutinho AF, Hatab MC, Falqueto A, Rezende HR, Duarte AM, Collins W, Malafronte RS, Malar J 2007 6 33 10.1186/1475-2875-6-33 17371598 (Pubitemid 46512736)
21. The indirect fluorescent antibody test for malaria. Collins EC, Skinner JC, Am J Top Med Hyg 1972 21 690 695
22. Application of the indirect fluorescent antibody assay in the study of malaria infection in the Yangtze River Three Gorges Reservoir, China. Wang DQ, Tang LH, Gu ZC, Zheng X, Yang MN, Malar J 2009 8 199 10.1186/1475-2875-8-199 19678949
23. Indirect fluorescent-antibody tests for parasitic diseases. V. An evaluation of a thick-smear antigen in the IFA test for malaria antibodies. Sulzer AJ, Wilson M, Hall EC, Am J Trop Med Hyg 1969 18 199 205 4888028
24. DNA sequencing and expression of the circumsporozoite protein of Plasmodium vivax Korean isolate in Escherichia coli. Lee HW, Lee WJ, Lee JS, Lee HS, Kor J Microbiol 1999 37 234 242 (Pubitemid 129633693)
25. Molecular cloning and expression of the VK247 circumsporozoite protein for serodiagnosis of variant form Plasmodium vivax. Kim TS, Kim HH, Oh CM, Lee SS, Choi KM, Lin K, Kim JY, Na BK, Sohn Y, Kim H, Lee HW, Parasitol Res 2011 108 1275 1282 10.1007/s00436-010-2177-3 21318386
26. Blocking effect of a monoclonal antibody against recombinant Pvs25 on sporozoite development in Anopheles sinensis. Moon SU, Kim HH, Kim TS, Choi KM, Oh CM, Ahn YJ, Hwang SK, Sohn Y, Shin EH, Kim H, Lee HW, Clin Vaccine Immunol 2010 17 1183 1187 10.1128/CVI.00101-10 20554802
27. The role of Pvs28 in sporozoite development in Anopheles sinensis and its longevity in BALB/c. Kim TS, Kim HH, Moon SU, Lee SS, Shin EH, Oh CM, Kang YJ, Kim DK, Sohn Y, Kim H, Lee HW, Exp Parasitol 2011 127 346 350 10.1016/j.exppara.2010.08.015 20801117
28. High levels of antibodies to Plasmodium falciparum liver stage antigen-1 in naturally infected individuals in Myanmar. Lee HW, Moon SU, Kim YJ, Cho SH, Lin K, Na BK, Kim TS, Kor J Parasitol 2008 46 195 198 10.3347/kjp.2008.46.3.195
29. Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection. Lee HW, Moon SU, Ryu HS, Kim YJ, Cho SH, Chung GT, Lin K, Na BK, Kong Y, Chung KS, Kim TS, Kor J Parasitol 2006 44 49 54 10.3347/kjp.2006.44.1.49